Global Combined Hormonal Contraceptives Market Reviewed in Topical Daedal Research Report Available at

24 Feb 2015 • by Natalie Aster

LONDON - Containing two types of hormones, combined hormone contraceptives (CHCs) are available in the form of skin dispatches, pills and vaginal rings. Taken in order to prevent pregnancy, they work by stopping ovulation and are considered to be an excellent method of birth control. For instance, less that 1 percent of typical users will experience an accidental pregnancy in the 1st year. The CHC products are mainly used in the age group of 15-49 years.

Other advantages that CHCs provide, include treatment of menstrual cramping and bleeding, irregular menstrual flow, endometriosis, and more.

Nuvaring and Ortho Evra are products enjoying the largest demand. An increase of health awareness and consciousness; a rise in healthcare expenditure; urbanization and growth in government initiatives aimed to encourage the use of CHC products, the market continues growing. However, strict regulatory compliance as well as serious adverse events restrain growth of the market.

Currently, a large number of M&A activities take place, while the demand for reversible method of contraception with a small number of side effects is on the rise.

New market research study “Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19)” developed by Daedal Research offers a comprehensive guide to the global market for CHC products. The report contains an all-round overview of the market, covering classification, a mechanism of action, components of products, details on advantages and disadvantages of such products, risks, and more. The study provides valuable information on the market size and growth, besides discussing performance of CHC generic market and CHC branded market. It also unveils market growth drivers, challenges and trends. The report highlights the competitive landscape and market opportunities and includes company profiles. Future market outlook to 2019 can be found in the research study too.

Report Details:

Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19)
Published: January, 2015
Pages: 64
Price: US$ 800.00

Other cutting-edge research studies by the publisher can be found at Daedal Research page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970